Avantor Stock Forecast, Price & News

Avantor's stock was trading at $12.92 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AVTR shares have increased by 89.2% and is now trading at $24.44.
View which stocks have been most impacted by COVID-19.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Avantor.

Avantor is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Avantor.

Avantor will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Avantor Inc (NYSE:AVTR) announced its quarterly earnings data on Wednesday, July, 29th. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.05. The company earned $1.48 billion during the quarter, compared to analyst estimates of $1.49 billion. The business's revenue for the quarter was down 3.5% on a year-over-year basis. During the same period last year, the company earned $0.14 earnings per share.
View Avantor's earnings history.

Avantor issued an update on its third quarter 2020 Pre-Market earnings guidance on Friday, October, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.6-1.6 billion, compared to the consensus revenue estimate of $1.54 billion.

16 analysts have issued 12 month price targets for Avantor's shares. Their forecasts range from $15.00 to $30.00. On average, they anticipate Avantor's stock price to reach $22.30 in the next year. This suggests that the stock has a possible downside of 8.8%.
View analysts' price targets for Avantor.

Avantor saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 13,610,000 shares, a drop of 17.2% from the September 15th total of 16,430,000 shares. Based on an average daily volume of 5,050,000 shares, the short-interest ratio is currently 2.7 days. Approximately 2.6% of the shares of the company are short sold.
View Avantor's Short Interest.

Some companies that are related to Avantor include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), (BIO.B) (BIO.B), 10x Genomics (TXG), PerkinElmer (PKI), Waters (WAT), Bruker (BRKR), Berkeley Lights (BLI), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Quanterix (QTRX) and Accelerate Diagnostics (AXDX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Honeywell International (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), The Procter & Gamble (PG), Raytheon Technologies (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

(AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Country Trust Bank (0.31%), Obermeyer Wood Investment Counsel Lllp (0.26%), Peregrine Capital Management LLC (0.16%), Norris Perne & French LLP MI (0.11%), CHURCHILL MANAGEMENT Corp (0.06%) and Deltec Asset Management LLC (0.05%). Company insiders that own Avantor stock include Devashish Ohri, Gerard Brophy, Jo Natauri, Justin Miller, Michael Wondrasch and New Mountain Investments Iii,.
View institutional ownership trends for Avantor.

AVTR stock was sold by a variety of institutional investors in the last quarter, including Country Trust Bank, Deltec Asset Management LLC, Peregrine Capital Management LLC, Candriam Luxembourg S.C.A., Standard Life Aberdeen plc, Norris Perne & French LLP MI, and First Hawaiian Bank. Company insiders that have sold Avantor company stock in the last year include Devashish Ohri, Gerard Brophy, Jo Natauri, Justin Miller, Michael Wondrasch, and New Mountain Investments Iii,.
View insider buying and selling activity for Avantor.

AVTR stock was acquired by a variety of institutional investors in the last quarter, including Obermeyer Wood Investment Counsel Lllp, CHURCHILL MANAGEMENT Corp, Polaris Wealth Advisory Group LLC, Forsta AP Fonden, Envestnet Asset Management Inc., Chesley Taft & Associates LLC, Sheets Smith Wealth Management, and IBM Retirement Fund.
View insider buying and selling activity for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $24.44.

Avantor has a market capitalization of $14.09 billion and generates $6.04 billion in revenue each year. Avantor employs 12,000 workers across the globe.

The official website for Avantor is www.avantorsciences.com.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]